Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹0 Cr
Revenue (TTM)
₹22 Cr
Net Profit (TTM)
₹-30 Cr
ROE
0 %
ROCE
-174.7 %
P/E Ratio
--
P/B Ratio
--
Industry P/E
--
EV/EBITDA
--
Div. Yield
-- %
Debt to Equity
-1.3
Book Value
₹-17.9
EPS
₹-31.8
Face value
10
Shares outstanding
8,945,650
CFO
-11.18 Cr
EBITDA
-25.90 Cr
Net Profit
-30.57 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
BSE Sensex
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
BSE IT
| -20.5 | -1.6 | -20.7 | -17.1 | 0.9 | 1.8 | 10.0 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
No Review & Analysis are available.
--
Incorporated
1995
Chairman
--
Managing Director
G Pradeep Ramayya
Headquarters
Hyderabad, Andhra Pradesh
Website
--
Since, TTM earnings of Axsys Healthtech Ltd is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2013
|
0.00
|
0.00
|
|
2012
|
0.00
|
0.00
|
|
2011
|
0.00
|
0.00
|
|
2007
|
0.00
|
0.00
|
|
2006
|
0.00
|
0.00
|
The 52-week high and low of Axsys Healthtech Ltd are Rs -- and Rs -- as of 05-Apr-2026.
Axsys Healthtech Ltd has a market capitalisation of ₹ 0 Cr as on . As per SEBI classification, it is a company.
Before investing in Axsys Healthtech Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.